A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Clinical trial NCT02150967 · TERMINATED
Trial details
- NCT number
- NCT02150967
- Sponsor
- QED Therapeutics, a BridgeBio company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-23
- Primary completion
- 2021-03-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.